Statin treatment is associated with reduction in serum levels of receptor activator of NF- B ligand and neutrophil activation in patients with severe carotid stenosis

Sébastien Lenglet, Alessandra Quercioli, Mathias Fabre, Katia Galan, Graziano Pelli, Alessio Nencioni, Inga Bauer, Aldo Pende, Magaly Python, Maria Bertolotto, Giovanni Spinella, Bianca Pane, Domenico Palombo, Franco Dallegri, François Mach, Nicolas Vuilleumier, Fabrizio Montecucco

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Systemic and intraplaque biomarkers have been widely investigated in clinical cohorts as promising surrogate parameters of cardiovascular vulnerability. In this pilot study, we investigated if systemic and intraplaque levels of calcification biomarkers were affected by treatment with a statin in a cohort of patients with severe carotid stenosis and being asymptomatic for ischemic stroke. Patients on statin therapy had reduced serum osteopontin (OPN), RANKL/osteoprotegerin (OPG) ratio, and MMP-9/pro-MMP-9 activity as compared to untreated patients. Statin-treated patients exhibited increased levels of collagen and reduced neutrophil infiltration in downstream portions of carotid plaques as compared to untreated controls. In upstream plaque portions, OPG content was increased in statin-treated patients as compared to controls. Other histological parameters (such as lipid, macrophage, smooth muscle cell, and MMP-9 content) as well as RANKL, RANK, and OPG mRNA levels did not differ between the two patient groups. Serum RANKL/OPG ratio positively correlated with serum levels of neutrophilic products, intraplaque neutrophil, and MMP-9 content within downstream portions of carotid plaques. In conclusion, statin treatment was associated with improvement in serum RANKL levels and reduced neutrophil activity both systemically and in atherosclerotic plaques.

Original languageEnglish
Article number720987
JournalMediators of Inflammation
Volume2014
DOIs
Publication statusPublished - 2014

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Neutrophil Activation
Carotid Stenosis
Osteoprotegerin
Ligands
Matrix Metalloproteinases
Serum
Neutrophils
Therapeutics
Biomarkers
Osteopontin
Neutrophil Infiltration
Atherosclerotic Plaques
Smooth Muscle Myocytes
Collagen
Stroke
Macrophages
Lipids
Messenger RNA

ASJC Scopus subject areas

  • Immunology
  • Cell Biology

Cite this

Statin treatment is associated with reduction in serum levels of receptor activator of NF- B ligand and neutrophil activation in patients with severe carotid stenosis. / Lenglet, Sébastien; Quercioli, Alessandra; Fabre, Mathias; Galan, Katia; Pelli, Graziano; Nencioni, Alessio; Bauer, Inga; Pende, Aldo; Python, Magaly; Bertolotto, Maria; Spinella, Giovanni; Pane, Bianca; Palombo, Domenico; Dallegri, Franco; Mach, François; Vuilleumier, Nicolas; Montecucco, Fabrizio.

In: Mediators of Inflammation, Vol. 2014, 720987, 2014.

Research output: Contribution to journalArticle

Lenglet, S, Quercioli, A, Fabre, M, Galan, K, Pelli, G, Nencioni, A, Bauer, I, Pende, A, Python, M, Bertolotto, M, Spinella, G, Pane, B, Palombo, D, Dallegri, F, Mach, F, Vuilleumier, N & Montecucco, F 2014, 'Statin treatment is associated with reduction in serum levels of receptor activator of NF- B ligand and neutrophil activation in patients with severe carotid stenosis', Mediators of Inflammation, vol. 2014, 720987. https://doi.org/10.1155/2014/720987
Lenglet, Sébastien ; Quercioli, Alessandra ; Fabre, Mathias ; Galan, Katia ; Pelli, Graziano ; Nencioni, Alessio ; Bauer, Inga ; Pende, Aldo ; Python, Magaly ; Bertolotto, Maria ; Spinella, Giovanni ; Pane, Bianca ; Palombo, Domenico ; Dallegri, Franco ; Mach, François ; Vuilleumier, Nicolas ; Montecucco, Fabrizio. / Statin treatment is associated with reduction in serum levels of receptor activator of NF- B ligand and neutrophil activation in patients with severe carotid stenosis. In: Mediators of Inflammation. 2014 ; Vol. 2014.
@article{30313ffe84274dd2980fb540ef71b3f4,
title = "Statin treatment is associated with reduction in serum levels of receptor activator of NF- B ligand and neutrophil activation in patients with severe carotid stenosis",
abstract = "Systemic and intraplaque biomarkers have been widely investigated in clinical cohorts as promising surrogate parameters of cardiovascular vulnerability. In this pilot study, we investigated if systemic and intraplaque levels of calcification biomarkers were affected by treatment with a statin in a cohort of patients with severe carotid stenosis and being asymptomatic for ischemic stroke. Patients on statin therapy had reduced serum osteopontin (OPN), RANKL/osteoprotegerin (OPG) ratio, and MMP-9/pro-MMP-9 activity as compared to untreated patients. Statin-treated patients exhibited increased levels of collagen and reduced neutrophil infiltration in downstream portions of carotid plaques as compared to untreated controls. In upstream plaque portions, OPG content was increased in statin-treated patients as compared to controls. Other histological parameters (such as lipid, macrophage, smooth muscle cell, and MMP-9 content) as well as RANKL, RANK, and OPG mRNA levels did not differ between the two patient groups. Serum RANKL/OPG ratio positively correlated with serum levels of neutrophilic products, intraplaque neutrophil, and MMP-9 content within downstream portions of carotid plaques. In conclusion, statin treatment was associated with improvement in serum RANKL levels and reduced neutrophil activity both systemically and in atherosclerotic plaques.",
author = "S{\'e}bastien Lenglet and Alessandra Quercioli and Mathias Fabre and Katia Galan and Graziano Pelli and Alessio Nencioni and Inga Bauer and Aldo Pende and Magaly Python and Maria Bertolotto and Giovanni Spinella and Bianca Pane and Domenico Palombo and Franco Dallegri and Fran{\cc}ois Mach and Nicolas Vuilleumier and Fabrizio Montecucco",
year = "2014",
doi = "10.1155/2014/720987",
language = "English",
volume = "2014",
journal = "Mediators of Inflammation",
issn = "0962-9351",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Statin treatment is associated with reduction in serum levels of receptor activator of NF- B ligand and neutrophil activation in patients with severe carotid stenosis

AU - Lenglet, Sébastien

AU - Quercioli, Alessandra

AU - Fabre, Mathias

AU - Galan, Katia

AU - Pelli, Graziano

AU - Nencioni, Alessio

AU - Bauer, Inga

AU - Pende, Aldo

AU - Python, Magaly

AU - Bertolotto, Maria

AU - Spinella, Giovanni

AU - Pane, Bianca

AU - Palombo, Domenico

AU - Dallegri, Franco

AU - Mach, François

AU - Vuilleumier, Nicolas

AU - Montecucco, Fabrizio

PY - 2014

Y1 - 2014

N2 - Systemic and intraplaque biomarkers have been widely investigated in clinical cohorts as promising surrogate parameters of cardiovascular vulnerability. In this pilot study, we investigated if systemic and intraplaque levels of calcification biomarkers were affected by treatment with a statin in a cohort of patients with severe carotid stenosis and being asymptomatic for ischemic stroke. Patients on statin therapy had reduced serum osteopontin (OPN), RANKL/osteoprotegerin (OPG) ratio, and MMP-9/pro-MMP-9 activity as compared to untreated patients. Statin-treated patients exhibited increased levels of collagen and reduced neutrophil infiltration in downstream portions of carotid plaques as compared to untreated controls. In upstream plaque portions, OPG content was increased in statin-treated patients as compared to controls. Other histological parameters (such as lipid, macrophage, smooth muscle cell, and MMP-9 content) as well as RANKL, RANK, and OPG mRNA levels did not differ between the two patient groups. Serum RANKL/OPG ratio positively correlated with serum levels of neutrophilic products, intraplaque neutrophil, and MMP-9 content within downstream portions of carotid plaques. In conclusion, statin treatment was associated with improvement in serum RANKL levels and reduced neutrophil activity both systemically and in atherosclerotic plaques.

AB - Systemic and intraplaque biomarkers have been widely investigated in clinical cohorts as promising surrogate parameters of cardiovascular vulnerability. In this pilot study, we investigated if systemic and intraplaque levels of calcification biomarkers were affected by treatment with a statin in a cohort of patients with severe carotid stenosis and being asymptomatic for ischemic stroke. Patients on statin therapy had reduced serum osteopontin (OPN), RANKL/osteoprotegerin (OPG) ratio, and MMP-9/pro-MMP-9 activity as compared to untreated patients. Statin-treated patients exhibited increased levels of collagen and reduced neutrophil infiltration in downstream portions of carotid plaques as compared to untreated controls. In upstream plaque portions, OPG content was increased in statin-treated patients as compared to controls. Other histological parameters (such as lipid, macrophage, smooth muscle cell, and MMP-9 content) as well as RANKL, RANK, and OPG mRNA levels did not differ between the two patient groups. Serum RANKL/OPG ratio positively correlated with serum levels of neutrophilic products, intraplaque neutrophil, and MMP-9 content within downstream portions of carotid plaques. In conclusion, statin treatment was associated with improvement in serum RANKL levels and reduced neutrophil activity both systemically and in atherosclerotic plaques.

UR - http://www.scopus.com/inward/record.url?scp=84896832281&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896832281&partnerID=8YFLogxK

U2 - 10.1155/2014/720987

DO - 10.1155/2014/720987

M3 - Article

C2 - 24648660

AN - SCOPUS:84896832281

VL - 2014

JO - Mediators of Inflammation

JF - Mediators of Inflammation

SN - 0962-9351

M1 - 720987

ER -